Neuroscience has entered a new era. Now it’s time for a ‘moonshot’ approach.
PharmaVoice
by Meagan Parrish
6h ago
Dr. Jeremy Levin, CEO of Ovid Therapeutics, explains how scientific advances have converged to create a new era of drug development potential ..read more
Visit website
As Lilly and BMS invest in manufacturing, demand for drugs still outweighs supply
PharmaVoice
by Michael Gibney
1d ago
From popular weight loss drugs to lifesaving cancer therapies, recent pharma deals show the industry is doubling down on manufacturing capacity to meet demand ..read more
Visit website
Biogen: Don’t expect any big acquisitions this year
PharmaVoice
by Jacob Bell
1d ago
While the company is eager to diversify, CEO Chris Viehbacher said that in the near-term any dealmaking would likely focus on collaborations and early-stage assets ..read more
Visit website
AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy
PharmaVoice
by Amy Baxter
2d ago
After a successful mid-stage study, the companies aim to upend traditional wet AMD treatments with a one-time gene therapy ..read more
Visit website
Inside J&J’s strategy to de-gender clinical trials
PharmaVoice
by Alexandra Pecci
2d ago
Mark Wildgust, vice president of global medical affairs for J&J's oncology division, shares strategies for making clinical trials gender- and trans-inclusive ..read more
Visit website
WuXi partnerships at risk as lawmakers target Chinese ties to biopharma
PharmaVoice
by Amy Baxter
4d ago
Why the legislation could throw a wrench into the supply chain for advanced therapies and how the industry has responded ..read more
Visit website
Vistagen’s on-demand nasal spray could provide a novel option for social anxiety
PharmaVoice
by Kelly Bilodeau
4d ago
The fast-acting medication is one of a few new approaches being tested for the crippling condition ..read more
Visit website
Roivant spinoff tackles growing complexity of clinical trials
PharmaVoice
by Kelly Bilodeau
1w ago
As precision medicine booms, all trials are starting to look like rare disease trials, the company said ..read more
Visit website
3 patent expirations in 2024 and how companies are pivoting
PharmaVoice
by Amy Baxter
1w ago
As the cliffs approach, pharma companies are tackling the sales hit with diverging strategies ..read more
Visit website
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
PharmaVoice
by Meagan Parrish
1w ago
New clinical trial starts are picking back up, but are still far below their bustling pre-war level.  ..read more
Visit website

Follow PharmaVoice on FeedSpot

Continue with Google
Continue with Apple
OR